HMA-EMA’s work programme on availability of authorized medicines for human and veterinary use includes measures for Brexit

On 23 August 2018, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), the network of the National Competent Authorities in the European Economic Area (EEA), published the work program of their joint task force regarding the availability of authorized medicines for human and veterinary use. The HMA-EMA task force was created

The post HMA-EMA’s work programme on availability of authorised medicines for human and veterinary use includes measures for Brexit appeared first on Focus on Regulation.

Share Back to main blog
Loading data